First Time Loading...
F

Fresenius SE & Co KGaA
XETRA:FRE

Watchlist Manager
Fresenius SE & Co KGaA
XETRA:FRE
Watchlist
Price: 28.13 EUR 0.93% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one FRE stock under the Base Case scenario is 56.11 EUR. Compared to the current market price of 28.13 EUR, Fresenius SE & Co KGaA is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FRE Relative Value
Base Case
56.11 EUR
Undervaluation 50%
Relative Value
Price
F
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
6
vs Industry
74
Median 3Y
0.5
Median 5Y
0.5
Industry
2.4
Forward
0.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
24
Median 3Y
10.4
Median 5Y
10.9
Industry
23.4
Forward
9.4
More Details
3.6
P/OCF
P/OCF
Price to OCF
3.6
vs History
52
vs Industry
49
Median 3Y
3.6
Median 5Y
3.6
Industry
15.5
More Details
4
P/FCFE
P/FCFE
Price to FCFE
4
vs History
93
vs Industry
39
Median 3Y
10.4
Median 5Y
10.1
Industry
23.2
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
66
vs Industry
68
Median 3Y
0.8
Median 5Y
1
Industry
2.3
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
30
vs Industry
64
Median 3Y
1.1
Median 5Y
1.1
Industry
2.5
Forward
1.1
More Details
5.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.4
vs History
7
vs Industry
42
Median 3Y
4
Median 5Y
4
Industry
5.3
More Details
10.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.1
vs History
3
vs Industry
33
Median 3Y
6.3
Median 5Y
6.1
Industry
12.6
Forward
6.9
More Details
22.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.7
vs History
3
vs Industry
22
Median 3Y
10.9
Median 5Y
9.9
Industry
17.2
Forward
10.4
More Details
6.1
EV/OCF
EV/OCF
Enterprise Value to OCF
6.1
vs History
84
vs Industry
46
Median 3Y
8.6
Median 5Y
8.6
Industry
15.3
More Details
8.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.2
vs History
92
vs Industry
37
Median 3Y
15.2
Median 5Y
16.1
Industry
19.8
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
26
vs Industry
71
Median 3Y
0.6
Median 5Y
0.6
Industry
2
More Details

Multiples Across Competitors

FRE Competitors Multiples
Fresenius SE & Co KGaA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8B EUR 0.7 -26.7 10.1 22.7
US
Cigna Corp
NYSE:CI
98B USD 0.5 27.1 9.8 12.9
US
Cigna Group
XMUN:CGN
90.8B EUR 0.5 27 9.7 12.9
US
CVS Health Corp
NYSE:CVS
70.6B USD 0.2 9.6 8.7 8.7
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD 1.4 39.1 11.9 17.9
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD 1.6 18 10.7 14.5
DE
Fresenius Medical Care AG
XMUN:FME
11.5B EUR 0.6 23 6.9 16.3
US
DaVita Inc
NYSE:DVA
12.1B USD 1 14.8 8.3 11.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR 0.6 22 6.7 15.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5
US
Chemed Corp
NYSE:CHE
8.7B USD 3.8 30.6 19.2 22.4

See Also

Summary
FRE intrinsic value, competitors valuation, and company profile.
DCF Valuation
FRE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FRE stock valuation using valuation multiples.
Wall Street Estimates
FRE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FRE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.